[UPCKat] Has the UPC set too high burden to stop generic entry in Boehringer Ingelheim v Zentiva?
The IPKat is left puzzled in Lisbon... The UPCKat is back to report on the ability to demonstrate imminent infringement, and how the Lisbon ...
Annsley Merelle Ward -
Tuesday, June 10, 2025
[UPCKat] Has the UPC set too high burden to stop generic entry in Boehringer Ingelheim v Zentiva?
Reviewed by Annsley Merelle Ward
on
Tuesday, June 10, 2025
Rating:
Reviewed by Annsley Merelle Ward
on
Tuesday, June 10, 2025
Rating: